Great Basin Scientific begins clinical trial for Shiga toxin-producing E. coli diagnostic test

NewsGuard 100/100 Score
Feb 13 2015

Great Basin Scientific, Inc. (NASDAQ: GBSN), today announced it has initiated a clinical trial for its Shiga toxin-producing E. coli (STEC) diagnostic test. The Great Basin STEC diagnostic test will also detect serotype E. coli O157:H7.

This is the third clinical trial the Company has initiated since July 2014. In December of 2014, the Company initiated a clinical trial for its Staph ID/R (identification/resistance) blood sepsis diagnostic test. In 2012 the Company launched its FDA-cleared Toxigenic C. diff diagnostic test.

SOURCE Great Basin Scientific, Inc.

Posted in: Device / Technology News

Tags: , , , , , , , , ,

Comments (0)

Suggested Reading

Study shows daily glucose levels fluctuate more than we thought, challenging diabetes diagnosis
Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions
Screening for alcohol use disorder gets a diagnostic accuracy check-up
Study offers insights into E. coli contamination on leafy greens
Mediterranean diet and exercise reshape gut microbiome, aiding weight loss
MONET: New AI tool enhances medical imaging with deep learning and text analysis
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes
New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Gut bacteria and tryptophan diet can play a protective role against pathogenic E. coli